Driving immunometabolism to control lung infection

When drugs to kill microbes are ineffective, host-directed therapy uses the body's own immune system to deal with the infection. This approach is being tested in patients with COVID-19, and now a team of researchers has published a study showing how it might also work in the fight against tuberculosis (TB).